GSK2578215A
SIGMA/SML0660 - ≥98% (HPLC)
Synonym: 5-
CAS Number: 1285515-21-0
Empirical Formula (Hill Notation): C24H18FN3O2
Molecular Weight: 399.42
Linear Formula: C24H18FN3O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C24H18FN3O2/c25-23-14- |
| InChI key | WCIGMFCFPXZRMQ-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Fc1nccc(c1)c2cc(c(cc2)OCc |
| solubility | DMSO: 15 mg/mL, clear |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | GSK2578215A is a potent inhibitor of leucine-rich repeat kinase-2 (LRRK2) also known as dardarin or PARK8, a kinase with mutations linked to Parkinson’s disease. Because the most common mutation, G2019S, enhances LRRK2 kinase activity, it is hoped that LRRK2 inhibitors may be useful in treating the disease. GSK2578215A inhibited both wild-type and G2019S mutant LRRK2 kinase activity with IC50s of 10.9 and 8.9 nM respectively. It has good blood-brain barrier (BBB) permeability with a high ratio of brain to plasma distribution in mice. |
| Biochem/physiol Actions: | GSK2578215A is a potent inhibitor of leucine-rich repeat kinase-2 (LRRK2). |
| Biochem/physiol Actions: | GSK2578215A stimulates mitochondrial fragmentation, autophagy and mitophagy. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

